chr14-104712972-C-G
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4BP6BS1BS2
The NM_022489.4(INF2):āc.2755C>Gā(p.Leu919Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000546 in 1,612,470 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. L919L) has been classified as Likely benign.
Frequency
Consequence
NM_022489.4 missense
Scores
Clinical Significance
Conservation
Publications
- Charcot-Marie-Tooth disease dominant intermediate EInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet
- focal segmental glomerulosclerosis 5Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- familial idiopathic steroid-resistant nephrotic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152240Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000282 AC: 7AN: 248034 AF XY: 0.0000296 show subpopulations
GnomAD4 exome AF: 0.0000541 AC: 79AN: 1460230Hom.: 0 Cov.: 36 AF XY: 0.0000578 AC XY: 42AN XY: 726404 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152240Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74384 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Focal segmental glomerulosclerosis 5;C4302667:Charcot-Marie-Tooth disease dominant intermediate E Uncertain:1Benign:1
- -
- -
Inborn genetic diseases Uncertain:1
The c.2755C>G (p.L919V) alteration is located in exon 18 (coding exon 17) of the INF2 gene. This alteration results from a C to G substitution at nucleotide position 2755, causing the leucine (L) at amino acid position 919 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
INF2-related disorder Uncertain:1
The INF2 c.2755C>G variant is predicted to result in the amino acid substitution p.Leu919Val. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0097% of alleles in individuals of Ashkenazi Jewish descent in gnomAD (http://gnomad.broadinstitute.org/variant/14-105179309-C-G). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at